CONGRESS: 22–25 SEPTEMBER 2025
Congress in microcosm: examples of linking learning to the laboratory
In just three months, the biennial IBMS Congress will return to the ICC in Birmingham. The focus once again will be on the very best that biomedical science and those supporting the event have to offer. Here, Pathology in Practice focuses on a small selection of scientific programme abstracts, alphabetically from cellular pathology to haematology.
An investment in learning and development sums up Congress exactly. Change continues to happen in pathology at an almost unprecedented pace, and this is a challenge for those needing to broaden their skills and knowledge. This is where Congress ticks so many boxes. Over four days there will be over 300 lectures across 15 different subjects and specialties. The following provides a glimpse of what’s on the scientific programme.
The role of immunohistochemistry markers in distinguishing benign from malignant sarcoma Fitim Berisha
UK NEQAS ICC & ISH
The diagnosis of benign and malignant soft tissue and bone neoplasms can be challenging due to their rarity and histological diversity. In recent years, immunohistochemistry has become increasingly important in aiding diagnosis of sarcoma due to development of new markers able to detect proteins of specific gene alteration. One of such markers is signal transducer and activator of transcription 6 (STAT6). STAT6 was established as valuable diagnostic immunohistochemistry marker, following detection of the recurrent gene fusion product NAB2-STAT6 in most solitary fibrous tumour. STAT6 is a highly sensitive and specific immunohistochemistry
marker used to distinguishing solitary fibrous tumours from other morphological mimics.
The role of immunohistochemistry in diagnostic neuropathology of CNS tumours: A current update Dr Ashirward Merve Great Ormond Street Hospital for
Children NHS Foundation Trust and University College London Hospitals NHS Foundation Trust
Immunohistochemistry complements histological assessment and provides vital information about diagnosis and grading/ prognosis of tumours. This presentation aims to inform the audience of the
International Convention Centre: home to the biennial IBMS Congress event since 1995.
WWW.PATHOLOGYINPRACTICE.COM JUNE 2025 21
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
